Cyclacel Pharmaceuticals, Inc. - COM NEW (CYCC)

Historical Portfolio Holders from Q4 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
229K
Holdings value Q2 2024
$371K
Value change Q2 2024
+$263K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
16
Number of buys Q2 2024
6
Number of sells Q2 2024
-3
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 229K $371K +$263K $1.62 16
2024 Q1 60.6K $127K -$90.8K $2.11 12
2023 Q4 93.9K $250K +$249K $2.67 13